0001709409-23-000009.txt : 20230921 0001709409-23-000009.hdr.sgml : 20230921 20230920173236 ACCESSION NUMBER: 0001709409-23-000009 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230920 EFFECTIVENESS DATE: 20230921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allarity Therapeutics, Inc. CENTRAL INDEX KEY: 0001860657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-492628 FILM NUMBER: 231267284 BUSINESS ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 401-426-4664 MAIL ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 D 1 primary_doc.xml X0708 D LIVE 0001860657 Allarity Therapeutics, Inc. 24 SCHOOL ST., 2ND FLOOR BOSTON MA MASSACHUSETTS 02108 401-426-4664 DELAWARE None None Corporation true 2021 James Cullem 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Executive Officer Director Joan Brown 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Executive Officer Gerald McLaughlin 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Laura Benjamin 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Thomas Jensen 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Joseph Vazzano 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Biotechnology Decline to Disclose 06b false 2023-09-18 false true true true true Inducement Warrants to purchase common stock, and common stock issuable upon exercise of the Inducement Warrants false 0 A.G.P./Alliance Global Partners 8361 None None 88 Post Road West 2nd Floor West Port CT CONNECTICUT 06880 All States false Indefinite 1601578 Indefinite Based on initial exercise price of $1.00 of existing warrants from April Offering and July Offering ("Existing Warrants") exercised, and common stock issuable upon exercise of inducement warrants at exercise price of $1.00 per share false 2 170723 true 0 Financial advisory fee equal 7% of gross proceeds received from exercise of Existing Warrants for which Inducement Warrants issued 0 false Allarity Therapeutics, Inc. /s/ James G. Cullem James G. Cullem Chief Executive Officer 2023-09-19